Hyderabad-basically based entirely mostly biotech company engaged on growing a nasal vaccine for COVID-19

NATIONAL | April 5, 2020:

A worldwide collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies FluGen alongside with Bharat Biotech has begun the enchancment and attempting out of a vaccine against COVID-19 called CoroFlu.

Bharat Biotech will develop the vaccine, habits scientific trials, and put collectively to construct nearly 300 million doses of vaccine for global distribution.

Below the collaboration agreement, FluGen will transfer its present manufacturing processes to Bharat Biotech to enable the corporate to scale up manufacturing and construct the vaccine for scientific trials,” Dr. Raches Ella, Head of Business Construction, Bharat Biotech acknowledged.


Study More

Leave a Reply

Your email address will not be published. Required fields are marked *